Quinolone resistance in Helicobacter pylori isolates in Germany

被引：78

作者：

Glocker, Erik

Stueger, Hans-Peter

Kist, Manfred

机构：

[1] Univ Freiburg Klinikum, Inst Med Mikrobiol & Hyg, Dept Microbiol & Hyg, D-79104 Freiburg, Germany

[2] Austrian Agcy Hlth & Food Safety, Inst Biostat, Graz, Austria

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2007年 / 51卷 / 01期

关键词：

D O I：

10.1128/AAC.00614-06

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

We show that quinolone resistance in Helicobacter pylori has reached an alarming level in Germany. Our data suggest that the use of quinolones requires prior antimicrobial susceptibility testing, especially for isolates from patients who have already undergone previous unsuccessful eradication treatments, and also underline the further need for surveillance studies to monitor antibiotic resistance in H. pylori.

引用

收藏

页码：346 / 349

页数：4

相关论文

共 26 条

[1] Helicobacter pylori uptake and efflux:: Basis for intrinsic susceptibility to antibiotics in vitro [J].

Bina, JE ;

Alm, RA ;

Uria-Nickelsen, M ;

Thomas, SR ;

Trust, TJ ;

Hancock, REW .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) :248-254

[2] High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy [J].

Branca, G ;

Spanu, T ;

Cammarota, G ;

Schito, AM ;

Gasbarrini, A ;

Gasbarrini, GB ;

Fadda, G .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 (05) :433-438

[3] Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999) [J].

Cabrita, J ;

Oleastro, M ;

Matos, R ;

Manhente, A ;

Cabral, J ;

Barros, R ;

Lopes, AI ;

Ramalho, P ;

Neves, BC ;

Guerreiro, AS .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) :1029-1031

[4] Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection [J].

Cammarota, G ;

Cianci, R ;

Cannizzaro, O ;

Cuoco, L ;

Pirozzi, G ;

Gasbarrini, A ;

Armuzzi, A ;

Zocco, MA ;

Santarelli, L ;

Arancio, F ;

Gasbarrini, G .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (10) :1339-1343

[5] Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis [J].

Carratala, J ;

FernandezSevilla, A ;

Dominguez, FTMA ;

Gudiol, F .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (02) :503-505

[6] Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands [J].

Debets-Ossenkopp, YJ ;

Herscheid, AJ ;

Pot, RGJ ;

Kuipers, EJ ;

Kusters, JG ;

Vandenbroucke-Grauls, CMJE .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (04) :511-515

[7] In vitro activity of fluoroquinolone and the gyrA gene mutation in Helicobacter pylori strains isolated from children [J].

Fujimura, S ;

Kato, S ;

Iinuma, K ;

Watanabe, A .

JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 53 (10) :1019-1022

[8] Effects of 16S rRNA gene mutations on tetracycline resistance in Helicobacter pylori [J].

Gerrits, MM ;

Berning, M ;

Van Vliet, AHM ;

Kuipers, EJ ;

Kusters, JG .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (09) :2984-2986

[9] European Multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori [J].

Glupczynski, Y ;

Mégraud, F ;

Lopez-Brea, M ;

Andersen, LP .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2001, 20 (11) :820-823

[10] Fluoroquinolone consumption and resistance in haematology-oncology patients: ecological analysis in two university hospitals 1999-2002 [J].

Kern, WV ;

Steib-Bauert, M ;

de With, K ;

Reuter, S ;

Bertz, H ;

Frank, U ;

von Baum, H .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (01) :57-60